← Leaderboards
Sherry Morgan-Meadows
University Of Wisconsin Madison
$176,835
Attributed
$176,835
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $174.4K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$176,835 · 2
By mechanism
R21$174,352 · 1
M01$2,483 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- George Wilding$32,976,854
- Joan H Schiller$7,395,575
- Minesh P. Mehta$1,459,043
- Howard H Bailey$27,057,671
- James A Stewart$6,121,809
Others in their field
Top investigators on “Clinical Trial Phase Ii”
- Lawrence Corey · Fred Hutchinson Cancer Center$421,688,762
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Kimberly Smith · Ppd Development Lp$115,671,664
- Richard L Schilsky · University Of Chicago$114,474,127
- Philip J Disaia · University Of California Irvine$88,426,610
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
Research focus
Clinical Trial Phase IiDrug Adverse EffectNeoplasm /Cancer Chemotherapy